{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:10:40Z","timestamp":1781223040776,"version":"3.54.1"},"reference-count":47,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T00:00:00Z","timestamp":1227657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Stat Methods Med Res"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p>Hepatitis C virus (HCV) infection in Australia is predominantly transmitted through injecting drug use. A reduction in the heroin supply in Australia in late 2000 and early 2001 may have impacted the number of injecting drug users (IDUs) and the number of new hepatitis C infections. This paper updates estimates of HCV incidence between 1960 and 2005 and models long-term sequelae from infection. Outcomes among those with HCV were also recently assessed in a linkage study assessing cancer and causes of death following HCV diagnosis in New South Wales. Linkage study outcomes have been used here to calibrate modelled outcomes. Mathematical models were used to estimate HCV incidence among IDUs, migrants to Australia from high HCV-prevalence countries, and other HCV exposure groups. Recent trends in numbers of IDUs were based on indicators of injecting drug use. A natural history of HCV model was applied to estimate the prevalence of HCV in the population. Model predicted endpoints that were calibrated against the NSW linkage data over the period 1995\u20142002 were: (i) incident hepatocellular carcinoma (HCC); (ii) opioid overdose deaths; (iii) liver-related deaths; and (iv) all-cause mortality. Modelled estimates and the linkage data show reasonably good calibration for HCC cases and all-cause mortality. The estimated HCC incidence was increased from 70 cases in 1995 to 100 cases in 2002. All-cause mortality estimated at 1000 in 1995 increased to 1600 in 2002. Comparison of annual opioid deaths shows some agreement. However, the models underestimate the rate of increase observed between 1995 and 1999 and do not entirely capture the rapid decrease in overdose deaths from 2000 onwards. The linkage data showed a peak of overdose deaths at 430 in 1999 compared to 320 estimated by the models. Comparison of observed liver deaths with the modelled numbers showed poor agreement. A good agreement would require an increase in liver deaths from the assumed 2 to 5% per annum following cirrhosis in the models. Mathematical models suggest that HCV incidence decreased from a peak of 14,000 infections in 1999 to 9700 infections in 2005, largely attributable to a reduction in injecting drug use. The poor agreement between projected and linked liver deaths could reflect differing coding of causes of deaths, underestimates of the numbers of people with cirrhosis following HCV, or underestimates of rates of liver death following cirrhosis. The reasonably good agreement between most of the modelled estimates with observed linkage data provides some support for the assumptions used in the models.<\/jats:p>","DOI":"10.1177\/0962280208094689","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T21:09:04Z","timestamp":1227733744000},"page":"253-270","source":"Crossref","is-referenced-by-count":14,"title":["Modelling and calibration of the hepatitis C epidemic in Australia"],"prefix":"10.1177","volume":"18","author":[{"given":"K.","family":"Razali","sequence":"first","affiliation":[{"name":"National Centre in HIV Epidemiology and Clinical Research, the University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Amin","sequence":"additional","affiliation":[{"name":"National Centre in HIV Epidemiology and Clinical Research, the University of New South Wales, Sydney, NSW, Australia,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GJ","family":"Dore","sequence":"additional","affiliation":[{"name":"National Centre in HIV Epidemiology and Clinical Research, the University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MG","family":"Law","sequence":"additional","affiliation":[{"name":"National Centre in HIV Epidemiology and Clinical Research, the University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"HCV Projections Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2008,11,26]]},"reference":[{"key":"atypb1","volume-title":"Estimates and projections of the hepatitis C virus epidemic in Australia","author":"HCVPWG (Hepatitis C Virus Projections Working Group)","year":"1998"},{"key":"atypb2","volume-title":"Estimates and projections of the hepatitis C virus epidemic in Australia","author":"HCVPWG (Hepatitis C Virus Projections Working Group)","year":"2002"},{"key":"atypb3","volume-title":"Australian NSP Survey National Data Report 2000-2004","author":"Nchecr","year":"2005"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.02.014"},{"key":"atypb5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69374-4"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(02)00116-6"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1136\/jech.51.6.692"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7156.433"},{"key":"atypb9","volume-title":"HIV\/AIDS, hepatitis C and sexually transmissible infections in Australia: annual surveillance report, 2001","author":"NCHECR (National Centre in HIV Epidemiology and Clinical Research)."},{"key":"atypb10","volume-title":"3rd Australasian Conference on Hepatitis C","author":"Gilmour S."},{"key":"atypb11","volume-title":"HIV\/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report, 2004","author":"NCHECR (National Centre in HIV Epidemiology and Clinical Research)."},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00013-9"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01543.x"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.05.026"},{"key":"atypb15","first-page":"1100","volume":"14","author":"Law MG on behalf of the Hepatitis C Virus Projections Working Group.","year":"1999","journal-title":"J Hepatology"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00266.x"},{"key":"atypb17","volume-title":"Australian illicit drug report 1998-1999, 1999-2000, 2000-2001, 2001-2002, 2002-2003, and 2003-2004","author":"ABCI (Australian Bureau of Criminal Intelligence)","year":"1998"},{"key":"atypb18","volume-title":"National Drug Strategy Household Survey: Survey Report 1995","author":"CDHHS (Commonwealth Department of Health and Human Services)","year":"1996"},{"key":"atypb19","volume-title":"HIV\/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2005","author":"NCHECR (National Centre in HIV Epidemiology and Clinical Research)","year":"2005"},{"key":"atypb20","volume-title":"AIHW National Hospital Morbidity Database","author":"AIHW (Australian Institute of Health and Welfare)","year":"2006"},{"key":"atypb21","volume-title":"2003 Australian Bureau of Statistics data on accidental opioid induced deaths","author":"Degenhardt L.","year":"2004"},{"key":"atypb22","first-page":"65","volume":"28","author":"Dietze P.","year":"2004","journal-title":"Aust N Z J Pub Hlth"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1007\/BF00144820"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-12-200212170-00009"},{"key":"atypb25","first-page":"239","volume":"24","author":"Thuring EG","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.85.9.1272"},{"key":"atypb27","first-page":"703","volume":"27","author":"Kakepoto GN","year":"1996","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-4346(96)82012-3"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268897007899"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06527-7"},{"key":"atypb31","first-page":"398","volume":"52","author":"Khattak MF","year":"2002","journal-title":"J Pak Med Assoc"},{"key":"atypb32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2005.00651.x"},{"key":"atypb33","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.27831"},{"key":"atypb34","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)00097-0"},{"key":"atypb35","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9024300"},{"key":"atypb36","volume-title":"Deaths, Australia 2004. ABS Catalogue No. 3302.0","author":"ABS (Australian Bureau of Statistics)","year":"2005"},{"key":"atypb37","volume-title":"2004 National Drug Strategy Household Survey: First results. AIHW cat. No. PHE 15","author":"AIHW (Australian Institute of Health and Welfare)","year":"2005"},{"key":"atypb38","volume-title":"Settlement Reports 2005","author":"DIMIA (Department of Immigration and Multicultural and Indigenous Affairs)","year":"2005"},{"key":"atypb39","volume-title":"Longitudinal studies of drug dependence","author":"Thorley A.","year":"1981"},{"key":"atypb40","volume-title":"The Quantification of Drug Caused Morbidity and Mortality in Australia","author":"English D.","year":"1995"},{"key":"atypb41","volume-title":"Opioid Overdose Deaths in Australia, 2003 edition","author":"Ndarc."},{"key":"atypb42","author":"McDonald SA","year":"2008","journal-title":"Statistical Methods in Medical Research"},{"key":"atypb43","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20836"},{"key":"atypb44","volume-title":"New South Wales Drug Trends 2000: Findings from the Illicit Drug Reporting System (IDRS)","author":"Darke S.","year":"2001"},{"key":"atypb45","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00032.x"},{"key":"atypb46","volume-title":"Changes in heroin availability in Sydney, Australia in Early 2001. NDARC Technical Report","author":"Rouen D.","year":"2001"},{"key":"atypb47","volume-title":"Australian Drug Trends 2004: Findings from the Illicit Drug Reporting System (IDRS). NDARC Monograph No. 55","author":"Stafford J.","year":"2005"}],"container-title":["Statistical Methods in Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0962280208094689","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0962280208094689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:44:01Z","timestamp":1777679041000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0962280208094689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,26]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1177\/0962280208094689"],"URL":"https:\/\/doi.org\/10.1177\/0962280208094689","relation":{},"ISSN":["0962-2802","1477-0334"],"issn-type":[{"value":"0962-2802","type":"print"},{"value":"1477-0334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,26]]}}}